Dr. Morgan Leonides Cordero , MD
General Practice • Bayamon, PR
5 St. Bloque 6 #27 Santa Rosa, No.2
Bayamon, PR 009598815
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Morgan Cordero is listed in NPPES under General Practice.
-
NPI assigned on July 3, 2006; this date does not establish years in practice.
-
Published CMS data list 1,670 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Biktarvy (Bictegrav/Emtricit/Tenofov Ala) — 170 prescription fills, including refills.
- Descovy (Emtricitabine/Tenofov Alafenam) — 142 prescription fills, including refills.
- Rosuvastatin Calcium — 141 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 41 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 65% of clinicians listed under General Practice in Bayamon, PR (2024, 149 clinicians with data). Median for this group: 602. Middle half: 146 to 2,942.
Close to the middle for Part D prescriptions among clinicians listed under General Practice in Puerto Rico (2024, 2,628 clinicians with data). Median for this group: 1,253. Middle half: 239 to 5,097.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 1,088 in 2020 to 1,670 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
5 St. Bloque 6 #27 Santa Rosa
No.2
Bayamon, PR 009598815
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
1,755 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,701,388 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $700.54 across 15 records.
By nature of payment
- Food and Beverage: $700.54 across 15 records.
Reporting-company totals (3 largest of 4)
- Gilead Sciences, Inc.: $353.71 across 10 records.
- ViiV Healthcare Company: $298.05 across 3 records.
- Exact Sciences Corporation: $25.00 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Bayamon and Puerto Rico
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 65% of clinicians listed under General Practice in Bayamon, PR (2024, 149 clinicians with data). Median for this group: 602. Middle half: 146 to 2,942.
Close to the middle for clinicians listed under General Practice in Puerto Rico (2024, 2,628 clinicians with data). Median for this group: 1,253. Middle half: 239 to 5,097.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under General Practice in Bayamon, PR (2024, 149 clinicians with data). Median for this group: $10,805. Middle half: $2,337 to $164,977.
A higher Part D drug cost than 95% of clinicians listed under General Practice in Puerto Rico (2024, 2,628 clinicians with data). Median for this group: $34,007. Middle half: $2,958 to $213,188.
275 active clinicians are listed under General Practice with a practice address in Bayamon, PR (4,196 in Puerto Rico).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Bayamon
0.4% of these 275 clinicians have the CMS telehealth indicator.
25.5% of these 275 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 53% from 1,088 in 2020 to 1,670 in 2024.
- 2020: 1,088
- 2021: 1,515
- 2022: 1,561
- 2023: 1,479
- 2024: 1,670
-
30-day fills
30-day fills increased 51% from 1,160 in 2020 to 1,755 in 2024.
- 2020: 1,160
- 2021: 1,537
- 2022: 1,591
- 2023: 1,490
- 2024: 1,755
-
Part D drug cost
Part D drug cost increased 78% from $1,514,874 in 2020 to $2,701,388 in 2024.
- 2020: $1,514,874
- 2021: $2,122,457
- 2022: $2,515,816
- 2023: $2,515,019
- 2024: $2,701,388
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $408.27 in 2021 to $700.54 in 2025.
- 2021: $408.27
- 2022: $304.84
- 2023: $776.93
- 2024: $585.52
- 2025: $700.54
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 15 records totaling $700.54.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $127.98 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $126.79 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
CABENUVA | General | $125.00 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
DOVATO | General | $108.05 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
— | General | $65.00 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $25.60 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
Cologuard Collection Kit | General | $25.00 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
PIFELTRO | General | $23.78 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $21.95 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $21.95 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $14.45 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $5.67 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $5.00 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $2.23 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $2.09 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 170 | 5,280 | $699,259.21 | 24 |
| Descovy | Emtricitabine/Tenofov Alafenam | 142 | 4,260 | $313,196.29 | 21 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 141 | 4,470 | $864.37 | 23 |
| Tivicay | Dolutegravir Sodium | 96 | 2,880 | $222,135.13 | 15 |
| Isentress Hd | Raltegravir Potassium | 85 | 2,550 | $170,298.06 | 12 |
| Symtuza | Darunavir/Cob/Emtri/Tenof Alaf | 81 | 2,430 | $384,153.91 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 75 | 2,250 | $901.53 | — |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 68 | 2,100 | $3,675.15 | 11 |
| Isentress | Raltegravir Potassium | 64 | 1,920 | $127,041.63 | — |
| Juluca | Dolutegravir/Rilpivirine | 63 | 1,890 | $222,663.45 | — |
| Prezcobix | Darunavir/Cobicistat | 53 | 1,590 | $130,794.04 | — |
| Dovato | Dolutegravir Sodium/Lamivudine | 50 | 1,500 | $148,833.60 | — |
| Losartan Potassium | Losartan Potassium | 46 | 1,560 | $318.52 | 11 |
| Gabapentin | Gabapentin | 40 | 1,500 | $293.67 | — |
| Amlodipine Besylate | Amlodipine Besylate | 35 | 1,350 | $107.55 | — |
| Famotidine | Famotidine | 34 | 1,080 | $212.10 | — |
| Triumeq | Abacavir/Dolutegravir/Lamivudi | 32 | 960 | $122,548.04 | — |
| Etravirine | Etravirine | 31 | 930 | $29,800.51 | — |
| Ezetimibe | Ezetimibe | 28 | 960 | $304.80 | — |
| Lamivudine-Zidovudine | Lamivudine/Zidovudine | 24 | 720 | $2,279.23 | — |
| Efavirenz | Efavirenz | 21 | 630 | $2,833.10 | — |
| Montelukast Sodium | Montelukast Sodium | 19 | 690 | $147.80 | — |
| Emtricitabine | Emtricitabine | 18 | 540 | $7,640.17 | — |
| Lisinopril | Lisinopril | 17 | 750 | $75.14 | — |
| Carvedilol | Carvedilol | 17 | 750 | $122.74 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
Additional State Medicaid & Healthcare Payer Identifiers
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
General Practice
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated July 03, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other General Practices in Bayamon
- Dr. Jose Ayala-Medina, MD
- Dr. Sigdan Cruz Rios, MD
- Dr. Nilka Vazquez Lopez, MD
- Dr. Carlos Rached Richa, MD
- Dr. Hec Rivera, MD
- Dr. Hector Tirado Davila, MD
Mailing Address
Po Box 372278
Cayey, PR 007372278
Phone: 7879951313